Ensign Peak Advisors’s Usana Health Sciences USNA Stock Holding History

Ensign Peak Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,445	Closed	-$178K	–	1730
2025 Q3	$178K	Hold	6,445	–	–	﹤0.01%	1660
2025 Q2	$197K	Hold	6,445	–	–	﹤0.01%	1681
2025 Q1	$174K	Hold	6,445	–	–	﹤0.01%	1676
2024 Q4	$231K	Hold	6,445	–	–	﹤0.01%	1692
2024 Q3	$244K	Hold	6,445	–	–	﹤0.01%	1683
2024 Q2	$292K	Hold	6,445	–	–	﹤0.01%	1681
2024 Q1	$313K	Sell	6,445 -325	-5%	-$15.9K	﹤0.01%	1689
2023 Q4	$363K	Hold	6,770	–	–	﹤0.01%	1696
2023 Q3	$397K	Hold	6,770	–	–	﹤0.01%	1648
2023 Q2	$427K	Hold	6,770	–	–	﹤0.01%	1661
2023 Q1	$426K	Buy	6,770 +900	+15%	+$53.7K	﹤0.01%	1673
2022 Q4	$312K	Buy	5,870 +1,900	+48%	+$103K	﹤0.01%	1705
2022 Q3	$223K	Sell	3,970 -30	-0.8%	-$1.98K	﹤0.01%	1836
2022 Q2	$289K	Hold	4,000	–	–	﹤0.01%	1695
2022 Q1	$318K	Hold	4,000	–	–	﹤0.01%	1732
2021 Q4	$405K	Sell	4,000 -7,700	-66%	-$768K	﹤0.01%	1698
2021 Q3	$1.08M	Hold	11,700	–	–	﹤0.01%	1404
2021 Q2	$1.2M	Hold	11,700	–	–	﹤0.01%	1371
2021 Q1	$1.14M	Buy	11,700 +600	+5%	+$54.6K	﹤0.01%	1376
2020 Q4	$856K	Hold	11,100	–	–	﹤0.01%	1459
2020 Q3	$818K	Hold	11,100	–	–	﹤0.01%	1395
2020 Q2	$815K	Hold	11,100	–	–	﹤0.01%	1339
2020 Q1	$641K	Hold	11,100	–	–	﹤0.01%	1319
2019 Q4	$872K	Buy	+11,100	New	+$818K	﹤0.01%	1381

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ensign Peak Advisors's USNA Position: Q4 2025 in Review

Ensign Peak Advisors sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 6,445 shares — an estimated $178K sold.

Ensign Peak Advisors first reported a position in USNA in Q4 2019 and held it in 24 quarters. The position peaked at $1.2M in Q2 2021. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

Ensign Peak Advisors reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
Ensign Peak Advisors sold 6,445 Usana Health Sciences shares in Q4 2025, an estimated $178K.
Ensign Peak Advisors first reported a position in Usana Health Sciences in Q4 2019 and held it in 24 quarters.
Ensign Peak Advisors's Usana Health Sciences position peaked at $1.2M in Q2 2021.
121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.